Spain To Free Up Pharmacy Controls

8 October 1995

New recommendations relating to competition have been made in Spain which will affect pharmacies, among other sectors, reports Cinco Dias, the Spanish financial daily.

The Spanish committee dealing with the protection of competition has proposed more freedom in the setting-up of pharmacies. It has suggested that owners of pharmacies should no longer have to be qualified pharmacists, and that references to minimum distances between pharmacies and the number of inhabitants in the area should be dropped.

The pharmacy sector is one of the most regulated sectors in Spain, and the committee is suggesting a five-year transition period to adopt these proposals. Other changes that have been put forward include: allowing discounts on the prices of medicines; lifting sales restrictions on certain products outside pharmacies; and the freeing up of opening hours of pharmacies, with set minimum opening times.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight